MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 30 filers reported holding MERUS N V in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,000 | – | 3,131 | +31210.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 10 | -87.5% | 0.00% | – |
| Q1 2023 | $1,000 | 0.0% | 80 | -4.8% | 0.00% | – |
| Q4 2022 | $1,000 | – | 84 | +600.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 12 | -98.5% | 0.00% | – |
| Q1 2021 | $17,000 | +325.0% | 818 | +172.7% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -14.3% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 300 | +14900.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,424,000 | 19.47% |
| BVF INC/IL | 7,285,071 | $152,185,000 | 5.71% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 244,713 | $5,112,000 | 2.79% |
| Burrage Capital Management LLC | 130,683 | $2,730,000 | 2.21% |
| MPM BioImpact LLC | 700,879 | $14,641,000 | 1.84% |
| Sofinnova Investments, Inc. | 1,311,039 | $27,388,000 | 1.65% |
| Octagon Capital Advisors LP | 200,000 | $4,178,000 | 1.57% |
| Boxer Capital, LLC | 1,900,000 | $39,691,000 | 1.35% |
| DAFNA Capital Management LLC | 157,841 | $3,297,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,113,706 | $23,265,000 | 0.34% |